Effects of atorvastatin on insulinemia and other atherosclerotic markers in patients with coronary artery disease

被引：0
|
作者：
Kuryat, O. V. [1 ]
Yegorova, Y. V. [1 ]
机构：
[1] Dnepropetrovsk State Med Acad, Dept Hosp Therapy 1, Dnepropetrovsk, Ukraine
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2007年 / 8卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(07)71789-0
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：207 / 207
页数：1
相关论文
共 50 条
  • [1] EFFECTIVENESS OF ATORVASTATIN THERAPY IN CORRECTION OF THE ADDITIONAL ATHEROSCLEROTIC MARKERS IN PATIENTS WITH CORONARY ARTERY DISEASE
    Yegorova, Y. V.
    Kuryata, O. V.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 248 - 248
  • [2] MYELOPEROXIDASE LEVEL AND OTHER MARKERS IN PATIENTS WITH CORONARY ARTERY DISEASE
    Bozovic, D.
    Dragnic, S.
    Barhanovic, Gligorovic N.
    Antunovic, T.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S291 - S291
  • [3] The effects of atorvastatin therapy on endothelial function in patients with coronary artery disease
    Yildiz A.
    Cakar M.A.
    Baskurt M.
    Okcun B.
    Guzelsoy D.
    Coskun U.
    Cardiovascular Ultrasound, 5 (1)
  • [4] Effect of atorvastatin and gemfibrozil on inflammatory markers in dyslipidemic patients with and without coronary artery disease
    Jaramillo, PL
    Cubillos, L
    Casas, J
    Silva, F
    Oubiña, M
    Cachofeiro, V
    Lahera, V
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 11 - 11
  • [5] ATORVASTATIN EFFECTS ON INFLAMMATION AND PLATELET ACTIVATION MARKERS FOLLOWING DRUG ELUTING STENTING IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
    Hatzinikolaou-Kotsakou, E.
    Beleveslis, Th.
    Bobotis, G.
    Moschos, G.
    Reppas, E.
    Chantas, A.
    Mavrogiani, A.
    Tsakiridis, K.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 233 - 234
  • [6] Atorvastatin For Secondary Prevention in Patients With Coronary Artery Disease
    Zateyshchikova, A.
    Sidorenko, B. A.
    KARDIOLOGIYA, 2011, 51 (12) : 63 - 69
  • [7] Polyvascular extracoronary atherosclerotic disease in patients with coronary artery disease
    Przewlocki, Tadeusz
    Kablak-Ziembicka, Anna
    Kozanecki, Artur
    Rzeznik, Daniel
    Pieniazek, Piotr
    Musialek, Piotr
    Piskorz, Adam
    Sokolowski, Andrzej
    Roslawiecka, Agnieszka
    Tracz, Wieslawa
    KARDIOLOGIA POLSKA, 2009, 67 (8A) : 978 - 984
  • [8] Effect of atorvastatin on peripheral endothelial function and systemic inflammatory markers in patients with stable coronary artery disease
    Alber, Hannes Franz
    Frick, Matthias
    Sussenbacher, Alois
    Dorler, Jakob
    Dichtl, Wolfgang
    Stocker, Eva-Maria
    Pachinger, Otmar
    Weidinger, Franz
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2007, 157 (3-4) : 73 - 78
  • [9] A Therapeutic Effects of Atorvastatin on Genetic Damage in Coronary Artery Disease
    Gundapaneni, Kishore Kumar
    Shyamala, Nivas
    Galimudi, Rajesh Kumar
    Sahu, Sanjib Kumar
    Hanumanth, Surekha Rani
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2016, 10 (06) : OC28 - OC30
  • [10] The Spectrum of Atherosclerotic Coronary Artery Disease in HIV Patients
    Abdul Hakeem
    Sabha Bhatti
    Mehmet Cilingiroglu
    Current Atherosclerosis Reports, 2010, 12 : 119 - 124
12345